Works matching IS 09509232 AND DT 2013 AND VI 32 AND IP 20

Results: 11

The orphan receptor GPR55 drives skin carcinogenesis and is upregulated in human squamous cell carcinomas.
Published in:
Oncogene, 2013, v. 32, n. 20, p. 2534, doi. 10.1038/onc.2012.278
By:
- Pérez-Gómez, E;
- Andradas, C;
- Flores, J M;
- Quintanilla, M;
- Paramio, J M;
- Guzmán, M;
- Sánchez, C
Publication type:
Article
PGC-1β mediates adaptive chemoresistance associated with mitochondrial DNA mutations.
Published in:
Oncogene, 2013, v. 32, n. 20, p. 2592, doi. 10.1038/onc.2012.259
By:
- Yao, Z;
- Jones, A W E;
- Fassone, E;
- Sweeney, M G;
- Lebiedzinska, M;
- Suski, J M;
- Wieckowski, M R;
- Tajeddine, N;
- Hargreaves, I P;
- Yasukawa, T;
- Tufo, G;
- Brenner, C;
- Kroemer, G;
- Rahman, S;
- Szabadkai, G
Publication type:
Article
Autophagy restricts proliferation driven by oncogenic phosphatidylinositol 3-kinase in three-dimensional culture.
Published in:
Oncogene, 2013, v. 32, n. 20, p. 2543, doi. 10.1038/onc.2012.277
By:
- Chen, N;
- Eritja, N;
- Lock, R;
- Debnath, J
Publication type:
Article
Histone arginine methylation keeps RUNX1 target genes in an intermediate state.
Published in:
Oncogene, 2013, v. 32, n. 20, p. 2565, doi. 10.1038/onc.2012.274
By:
- Herglotz, J;
- Kuvardina, O N;
- Kolodziej, S;
- Kumar, A;
- Hussong, H;
- Grez, M;
- Lausen, J
Publication type:
Article
Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4.
Published in:
Oncogene, 2013, v. 32, n. 20, p. 2555, doi. 10.1038/onc.2012.275
By:
- Cittelly, D M;
- Finlay-Schultz, J;
- Howe, E N;
- Spoelstra, N S;
- Axlund, S D;
- Hendricks, P;
- Jacobsen, B M;
- Sartorius, C A;
- Richer, J K
Publication type:
Article
RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets.
Published in:
Oncogene, 2013, v. 32, n. 20, p. 2576, doi. 10.1038/onc.2012.266
By:
- Kent, O A;
- Fox-Talbot, K;
- Halushka, M K
Publication type:
Article
Rictor regulates cell migration by suppressing RhoGDI2.
Published in:
Oncogene, 2013, v. 32, n. 20, p. 2521, doi. 10.1038/onc.2012.287
By:
- Agarwal, N K;
- Chen, C-H;
- Cho, H;
- Boulbès, D R;
- Spooner, E;
- Sarbassov, D D
Publication type:
Article
Reduced in vivo lung metastasis of a breast cancer cell line after treatment with Herceptin mAb conjugated to chemotherapeutic drugs.
Published in:
Oncogene, 2013, v. 32, n. 20, p. 2527, doi. 10.1038/onc.2012.283
By:
- Garcia, A Galan;
- Nedev, H;
- Bijian, K;
- Su, J;
- Alaoui-Jamali, M A;
- Saragovi, H U
Publication type:
Article
Overexpression of the anti-apoptotic protein AVEN contributes to increased malignancy in hematopoietic neoplasms.
Published in:
Oncogene, 2013, v. 32, n. 20, p. 2586, doi. 10.1038/onc.2012.263
By:
- Eißmann, M;
- Melzer, I M;
- Fernández, S B M;
- Michel, G;
- Hrabě de Angelis, M;
- Hoefler, G;
- Finkenwirth, P;
- Jauch, A;
- Schoell, B;
- Grez, M;
- Schmidt, M;
- Bartholomae, C C;
- Newrzela, S;
- Haetscher, N;
- Rieger, M A;
- Zachskorn, C;
- Mittelbronn, M;
- Zörnig, M
Publication type:
Article
Emerging roles for the pro-oncogenic anterior gradient-2 in cancer development.
Published in:
Oncogene, 2013, v. 32, n. 20, p. 2499, doi. 10.1038/onc.2012.346
By:
- Chevet, E;
- Fessart, D;
- Delom, F;
- Mulot, A;
- Vojtesek, B;
- Hrstka, R;
- Murray, E;
- Gray, T;
- Hupp, T
Publication type:
Article
Cell-penetrating H4 tail peptides potentiate p53-mediated transactivation via inhibition of G9a and HDAC1.
Published in:
Oncogene, 2013, v. 32, n. 20, p. 2510, doi. 10.1038/onc.2012.273
By:
- Heo, K;
- Kim, J-S;
- Kim, K;
- Kim, H;
- Choi, J;
- Yang, K;
- An, W
Publication type:
Article